Association of Occlusive Retinal Vasculitis With Intravitreal Faricimab

Ye Li; Robert Chong; Adrian T Fung

doi:10.1001/jamaophthalmol.2024.0928

Association of Occlusive Retinal Vasculitis With Intravitreal Faricimab

JAMA Ophthalmol. 2024 May 1;142(5):489-491. doi: 10.1001/jamaophthalmol.2024.0928.

Authors

Ye Li¹, Robert Chong^{2

3}, Adrian T Fung^{2

4

5}

Affiliations

¹ Department of Ophthalmology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
² Save Sight Institute, Specialty of Clinical Ophthalmology and Eye Health, The University of Sydney, Sydney, New South Wales, Australia.
³ Sydney Eye Hospital, Sydney, New South Wales, Australia.
⁴ Department of Ophthalmology, Westmead Hospital, Sydney, New South Wales, Australia.
⁵ Department of Ophthalmology, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia.

PMID: 38517431
DOI: 10.1001/jamaophthalmol.2024.0928

No abstract available

Plain language summary

This case report describes a patient with attenuation of retinal arterioles and veins associated with 2 blot hemorrhages and pallor of the inferotemporal retina without emboli.

Publication types

Case Reports

MeSH terms

Aged
Antibodies, Monoclonal, Humanized / adverse effects
Antibodies, Monoclonal, Humanized / therapeutic use
Female
Fluorescein Angiography
Humans
Intravitreal Injections*
Male
Middle Aged
Retinal Artery Occlusion / chemically induced
Retinal Artery Occlusion / diagnosis
Retinal Artery Occlusion / drug therapy
Retinal Vasculitis* / chemically induced
Retinal Vasculitis* / diagnosis
Retinal Vasculitis* / drug therapy
Tomography, Optical Coherence